SARAH STRUMPF: Open Payments
NPI 1417611385 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 49 payments from 14 companies in 2025. Trend: 2023 $944 · 2024 $1,099 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $236 |
| ABBVIE INC. | 7 | $160 |
| Ferring Pharmaceuticals Inc. | 4 | $110 |
| Ardelyx, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Braintree Laboratories, Inc. | 1 | $37 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $24 |
Products named: XIFAXAN, REBYOTA, IBSRELA, RELISTOR, RINVOQ, DUPIXENT, LINZESS, SKYRIZI.
Industry payments across NY — which companies pay providers there.
